Cargando…

Validation of a Parkinson Disease Predictive Model in a Population-Based Study

Parkinson disease (PD) has a relatively long prodromal period that may permit early identification to reduce diagnostic testing for other conditions when patients are simply presenting with early PD symptoms, as well as to reduce morbidity from fall-related trauma. Earlier identification also could...

Descripción completa

Detalles Bibliográficos
Autores principales: Faust, Irene M., Racette, Brad A., Searles Nielsen, Susan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7054801/
https://www.ncbi.nlm.nih.gov/pubmed/32148753
http://dx.doi.org/10.1155/2020/2857608
_version_ 1783503260099805184
author Faust, Irene M.
Racette, Brad A.
Searles Nielsen, Susan
author_facet Faust, Irene M.
Racette, Brad A.
Searles Nielsen, Susan
author_sort Faust, Irene M.
collection PubMed
description Parkinson disease (PD) has a relatively long prodromal period that may permit early identification to reduce diagnostic testing for other conditions when patients are simply presenting with early PD symptoms, as well as to reduce morbidity from fall-related trauma. Earlier identification also could prove critical to the development of neuroprotective therapies. We previously developed a PD predictive model using demographic and Medicare claims data in a population-based case-control study. The area under the receiver-operating characteristic curve (AUC) indicated good performance. We sought to further validate this PD predictive model. In a randomly selected, population-based cohort of 115,492 Medicare beneficiaries aged 66–90 and without PD in 2009, we applied the predictive model to claims data from the prior five years to estimate the probability of future PD diagnosis. During five years of follow-up, we used 2010–2014 Medicare data to determine PD and vital status and then Cox regression to investigate whether PD probability at baseline was associated with time to PD diagnosis. Within a nested case-control sample, we calculated the AUC, sensitivity, and specificity. A total of 2,326 beneficiaries developed PD. Probability of PD was associated with time to PD diagnosis (p < 0.001, hazard ratio = 13.5, 95% confidence interval (CI) 10.6–17.3 for the highest vs. lowest decile of probability). The AUC was 83.3% (95% CI 82.5%–84.1%). At the cut point that balanced sensitivity and specificity, sensitivity was 76.7% and specificity was 76.2%. In an independent sample of additional Medicare beneficiaries, we again applied the model and observed good performance (AUC = 82.2%, 95% CI 81.1%–83.3%). Administrative claims data can facilitate PD identification within Medicare and Medicare-aged samples.
format Online
Article
Text
id pubmed-7054801
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-70548012020-03-07 Validation of a Parkinson Disease Predictive Model in a Population-Based Study Faust, Irene M. Racette, Brad A. Searles Nielsen, Susan Parkinsons Dis Research Article Parkinson disease (PD) has a relatively long prodromal period that may permit early identification to reduce diagnostic testing for other conditions when patients are simply presenting with early PD symptoms, as well as to reduce morbidity from fall-related trauma. Earlier identification also could prove critical to the development of neuroprotective therapies. We previously developed a PD predictive model using demographic and Medicare claims data in a population-based case-control study. The area under the receiver-operating characteristic curve (AUC) indicated good performance. We sought to further validate this PD predictive model. In a randomly selected, population-based cohort of 115,492 Medicare beneficiaries aged 66–90 and without PD in 2009, we applied the predictive model to claims data from the prior five years to estimate the probability of future PD diagnosis. During five years of follow-up, we used 2010–2014 Medicare data to determine PD and vital status and then Cox regression to investigate whether PD probability at baseline was associated with time to PD diagnosis. Within a nested case-control sample, we calculated the AUC, sensitivity, and specificity. A total of 2,326 beneficiaries developed PD. Probability of PD was associated with time to PD diagnosis (p < 0.001, hazard ratio = 13.5, 95% confidence interval (CI) 10.6–17.3 for the highest vs. lowest decile of probability). The AUC was 83.3% (95% CI 82.5%–84.1%). At the cut point that balanced sensitivity and specificity, sensitivity was 76.7% and specificity was 76.2%. In an independent sample of additional Medicare beneficiaries, we again applied the model and observed good performance (AUC = 82.2%, 95% CI 81.1%–83.3%). Administrative claims data can facilitate PD identification within Medicare and Medicare-aged samples. Hindawi 2020-02-21 /pmc/articles/PMC7054801/ /pubmed/32148753 http://dx.doi.org/10.1155/2020/2857608 Text en Copyright © 2020 Irene M. Faust et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Faust, Irene M.
Racette, Brad A.
Searles Nielsen, Susan
Validation of a Parkinson Disease Predictive Model in a Population-Based Study
title Validation of a Parkinson Disease Predictive Model in a Population-Based Study
title_full Validation of a Parkinson Disease Predictive Model in a Population-Based Study
title_fullStr Validation of a Parkinson Disease Predictive Model in a Population-Based Study
title_full_unstemmed Validation of a Parkinson Disease Predictive Model in a Population-Based Study
title_short Validation of a Parkinson Disease Predictive Model in a Population-Based Study
title_sort validation of a parkinson disease predictive model in a population-based study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7054801/
https://www.ncbi.nlm.nih.gov/pubmed/32148753
http://dx.doi.org/10.1155/2020/2857608
work_keys_str_mv AT faustirenem validationofaparkinsondiseasepredictivemodelinapopulationbasedstudy
AT racettebrada validationofaparkinsondiseasepredictivemodelinapopulationbasedstudy
AT searlesnielsensusan validationofaparkinsondiseasepredictivemodelinapopulationbasedstudy